Chemical Structure : BI-6c9
CAS No.: 791835-21-7
Catalog No.: PC-49740Not For Human Use, Lab Use Only.
BI-6C9 is a specific small molecule inhibitor of BH3 interacting-domain death agonist (Bid) with Kd of 20 uM, blocks the release of both cytochrome c and second mitochondria-derived activator of caspase from mitochondria.
Packing | Price | Stock | Quantity |
---|---|---|---|
25 mg | $258 | In stock | |
50 mg | $428 | In stock | |
100 mg | $728 | In stock | |
1 g | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BI-6C9 is a specific small molecule inhibitor of BH3 interacting-domain death agonist (Bid) with Kd of 20 uM, blocks the release of both cytochrome c and second mitochondria-derived activator of caspase from mitochondria.
BI-6C9 (10 µM) also inhibits the nuclear translocation of apoptosis-inducing factor AIF, preventing the death of ovarian OVCAR-3 cancer cells induced by IFN-α2a.
BI-6C9 prevents apoptosis in neurons treated with glutamate or oxygen-glucose deprivation.
BH3 interacting domain death agonist (Bid), a substrate of caspase-8, is activated in the Fas/Apo-1 (CD95), tumor necrosis factor (TNF)-α, and tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptor-mediated cell death.
M.Wt | 471.59 | |
Formula | C23H25N3O4S2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-[4-[(4-Aminophenyl)thio]phenyl]-4-[[(4-methoxyphenyl)sulfonyl]amino]-Butanamide |
1. Zhou H, et al. Mol Cancer. 2014 Mar 16;13:59.
2. Landshamer, S., et al. Cell Death Differ. 15(10), 1553-1563 (2008).
3. Culmsee, C. et al. J. Neurosci. 25(44), 10262-10272 (2005).
4. Becattini, B.,et al. Proc. Natl. Acad. Sci. USA 103(3), 12602-12606 (2006).
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright